Overview

Evaluation of Atorvastatin on Atherosclerosis Composition

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Atorvastatin on the coronary atherosclerosis plaque morphology.
Phase:
N/A
Details
Lead Sponsor:
Emory University
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium